Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples